Incyte s Revenues Take a Dive, Losses Narrow in Q1 | GenomeWeb

NEW YORK, May 4 (GenomeWeb News) - Incyte's revenues were almost cut in half, while its losses narrowed during Q1 of 2004, the company reported today.

 

Revenues for the quarter plummeted to $6.6 million, from $12.5 million during the same period last year. Incyte attributed this decrease to the discontinuation of its genomic data products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.